Cecile Gastaldi
Monaco, Monaco
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy.
Journal: Molecular therapy. Nucleic acids
Published: August 22, 2025
Improving angiogenesis ameliorates the efficacy of ASO-based exon skipping for the treatment of Duchenne muscular dystrophy.
Journal: Molecular therapy. Nucleic acids
Published: July 15, 2025
Combined 20-Hydroxyecdysone and Antisense-Mediated Exon Skipping Improve Functional Outcomes in a Mouse Model of Duchenne Muscular Dystrophy.
Journal: Nucleic acid therapeutics
Published: February 17, 2025
Valproic Acid Improves Antisense-Mediated Exon-Skipping Efficacy in mdx Mice.
Journal: International journal of molecular sciences
Published: January 13, 2025
Identification of miR-141 as a Regulator of Epidermal Homeostasis.
Journal: The Journal of investigative dermatology
Published: April 25, 2024
Identification and functional validation of SRC and RAPGEF1 as new direct targets of miR-203, involved in regulation of epidermal homeostasis.
Journal: Scientific reports
Published: January 27, 2023
A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma.
Journal: Molecular oncology
Published: December 04, 2022
Palmitic acid conjugation enhances potency of tricyclo-DNA splice switching oligonucleotides.
Journal: Nucleic acids research
Published: August 30, 2021
Long-Term Efficacy of AAV9-U7snRNA-Mediated Exon 51 Skipping in mdx52 Mice.
Journal: Molecular therapy. Methods & clinical development
Published: April 27, 2020
miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma.
Journal: Carcinogenesis
Published: December 31, 2013
CDC25A targeting by miR-483-3p decreases CCND-CDK4/6 assembly and contributes to cell cycle arrest.
Journal: Cell death and differentiation
Published: February 23, 2013
Last Updated: 09/26/2026